Opinion

» careers and clinical trials

Most Recent

image: Opinion: Three-Parent Embryos—A Slippery Slope?

Opinion: Three-Parent Embryos—A Slippery Slope?

By John D. Loike and Alan Kadish | June 14, 2018

The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.

0 Comments

image: Opinion: We Must Demand Evidence of Peer Review

Opinion: We Must Demand Evidence of Peer Review

By Nikolai Slavov | May 21, 2018

Peer review varies in quality and thoroughness. Making it publicly available could improve it.

3 Comments

image: Opinion: Taxable Tuition = Trouble for Graduate Students

Opinion: Taxable Tuition = Trouble for Graduate Students

By Michael T. Parker and Patricia M. Lawston | November 30, 2017

Our calculations find troubling increases in taxes if a US House–led tax plan succeeds, but tuition waivers, as the Senate bill has proposed, could actually reduce students’ tax burdens.

2 Comments

image: Opinion: Tales from the Nonacademic Career Path

Opinion: Tales from the Nonacademic Career Path

By Anna Kriebs | September 3, 2017

Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.

0 Comments

Overseeing assistant professors tasked with teaching freshmen how to conduct research revealed crucial gaps in STEM doctoral education. 

0 Comments

image: Opinion: Biobanking Has a Consent Dilemma

Opinion: Biobanking Has a Consent Dilemma

By Timothy Caulfield | July 25, 2017

Is the deep uncertainty surrounding fundamental legal and ethical norms putting biobanks in a precarious position? 

0 Comments

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By Peter Doshi | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

4 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By John D. Loike and Jennifer Miller | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By Paul S. Thaler | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

Popular Now

  1. Dartmouth Professor Investigated for Sexual Misconduct Retires
  2. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  3. Laxative Causes Long-Term Changes to Mouse Microbiome
  4. Probiotics Prevent Cholera in Animal Models